MISONIX, INC. (NASDAQ:MSON) Files An 8-K Results of Operations and Financial Condition

MISONIX, INC. (NASDAQ:MSON) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item 2.02. Results of Operations and Financial Condition

On May 2, 2017, Misonix, Inc. (the Company) issued a press
release announcing financial results of its third fiscal quarter
ended March 31, 2017. The press release is furnished and attached
hereto as Exhibit 99.1. The information in this Item and the
aforementioned press release shall not be deemed filed for
purposes of Section 18 of the Exchange Act, and is not
incorporated by reference into any filing of the Company, whether
made before or after the date of this report, regardless of any
general incorporation language in the filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits
Exhibit No. Description of Exhibit
99.1 Press Release dated May 2, 2017


About MISONIX, INC. (NASDAQ:MSON)

MISONIX, INC. (Misonix) is a surgical device company. The Company designs, manufactures and markets therapeutic ultrasonic products across the world for spine surgery, skull-based surgery, neurosurgery, wound and burn debridement, cosmetic surgery, laparoscopic surgery and other surgical applications. The Company’s products include BoneScalpel, BoneScalpel MIS System, SonicOne O.R. System and SonaStar. BoneScalpel is an ultrasonic cutting system with applications in orthopedic and reconstructive surgery, as well as neurosurgery. BoneScalpel MIS System offers deep cuts through osseous structures with minimal blood loss. Misonix SonicOne O.R. System is an ultrasonic surgical debridement system that allows surgeons to address the challenges chronic wounds present to them, the patient, and the health-care system. SonaStar is used for neurosurgical procedures, such as skull/non-skull base tumor resections, transnasal procedures and acoustic mengiomas.

MISONIX, INC. (NASDAQ:MSON) Recent Trading Information

MISONIX, INC. (NASDAQ:MSON) closed its last trading session down -0.15 at 10.65 with 1,243 shares trading hands.

An ad to help with our costs